Three-Gene Biomarker Panel for Multiple Sclerosis Identified in Humans
A study identified a three-gene biomarker panel (ELOVL1, GALK2, PRKCD) and two additional genes (IP6K2, FUCA1) associated with magnesium adenosine diphosphate (MgADP) that improve panel performance in distinguishing multiple sclerosis (MS) cases from healthy individuals. The biomarkers showed strong discriminative performance metrics.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
These findings suggest potential genetic contributions to MS pathogenesis, highlighting a three-gene panel that could aid in diagnosing or understanding the disease.
What this does not prove
The study is observational, lacking validation of gene dysregulation functions and exploration of the mechanisms linking genetic variants to gene expression.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-24
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceA candidate CD4⁺ T-cell gene expression panel for multiple sclerosis highlights MgADP-associated genes. ↗DOI: 10.1016/j.msard.2026.107944
Supporting passages (5)
study designGene expression profiling provides a more comprehensive view of molecular activity, and by combining this with modern machine learning approaches, novel cell type-specific biomarkers may be uncovered.
subjectsGiven that clinically isolated syndrome (CIS) is the earliest clinical manifestation of MS, we constructed a supervised machine learning model using CD4⁺ T cell expression data from people with CIS and healthy individuals to identify disease-specific gene signatures that differentiated people with MS from healthy individuals.
findingsTogether, we report a three-gene candidate biomarker panel for MS with an exploratory five-gene extension.
limitationsBased on these findings, we hypothesize that dysregulation of certain genes that are associated with MgADP may contribute to MS pathogenesis, which requires future functional validation.
publication datePublication date: 2026-09-24
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.